发明名称 |
1-Heterocyclylalkyl-3-sulfonylindole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
摘要 |
The present invention provides a compound of formula I and the use thereof for the treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor.
|
申请公布号 |
US7589108(B2) |
申请公布日期 |
2009.09.15 |
申请号 |
US20050238246 |
申请日期 |
2005.09.29 |
申请人 |
WYETH |
发明人 |
BERNOTAS RONALD CHARLES;LENICEK STEVEN EDWARD |
分类号 |
A61K31/454;C07D209/36;A61K31/404;A61K31/416;A61K31/4439;A61K31/4545;A61K31/4709;A61P1/00;A61P25/00;A61P25/08;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/34;A61P25/36;A61P43/00;C07D401/04;C07D401/06;C07D401/14;C07D403/02;C07D403/04;C07D403/06;C07D409/14 |
主分类号 |
A61K31/454 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|